Evidence-Based Complementary and Alternative Medicine / 2020 / Article / Tab 3

Research Article

Assessment of the Efficacy and Safety of Ivy Leaf (Hedera helix) Cough Syrup Compared with Acetylcysteine in Adults and Children with Acute Bronchitis

Table 3

Duration of symptoms at entry visit.

Duration of symptoms at entry visitEA 575®ACCTotal value

The average duration of symptoms at entry visit (days)2.41 ± 0.092.33 ± 0.172.40 ± 0.08NS

Mann–Whitney test; NS = not significant (e.g., ); N = number of subjects.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.